Mutational analyses of differentiation-dependent human papillomavirus type 18 enhancer elements in epithelial raft cultures of neonatal foreskin keratinocytes

Cell Growth and Differentiation

Volumn 8, Issue 7, 1997, Pages 751-762

  Parker, Jacqueline Nuss ^a   Zhao, Wei ^a   Janine Askins, K ^a   Broker, Thomas R ^a   Chow, Louise T ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL DIFFERENTIATION; CELL IMMORTALIZATION; ENHANCER REGION; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KERATINOCYTE; PREPUCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; WART VIRUS;

CELL DIFFERENTIATION; CELLS, CULTURED; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; ENHANCER ELEMENTS (GENETICS); EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; INFANT, NEWBORN; KERATINOCYTES; MOLONEY MURINE LEUKEMIA VIRUS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; POINT MUTATION; PROMOTER REGIONS (GENETICS); SKIN;

BACTERIA (MICROORGANISMS); HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 0030856539     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Stoler, M. H., Wolinsky, S. M., Whitbeck, A., Broker, T. R., and Chow, L. T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology, 172: 331-340, 1989.
2. Stoler, M. H., Whitbeck, A., Wolinsky, S. M., Broker, T. R., Chow, L. T., Howett, M. K., and Kreider, J. W. Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J. Virol., 64: 3310-3318, 1990.
3. Beyer, F. E., Stoler, M. H., Girardi, F., and Pfister, H. Cell differentiation-related gene expression of human papillomavirus 33. Med. Microbiol. Immunol., 179: 185-192, 1990.
4. Durst, M., Glitz, D., Schneider, A., and zur Hausen, H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology, 189: 132-140, 1992.
5. Scheffner, M., Romanczuk, H., Münger, K., Huibregtse, J. M., Mietz, J. A., and Howley, P. M. Functions of human papillomavirus proteins. Curr. Top. Microbiol. Immunol., 186: 83-99, 1994.
6. Chow, L T., and Broker, T. R. Small DNA tumor viruses. In: N. Nathanson (ed.), Viral Pathogenesis, pp. 267-302. Philadelphia: Lippincott-Raven Publishers, 1996.
7. Broker, T. R., Chow, L. T., Chin, M. T., Rhodes, C. R., Wolinsky, S. M., Whitbeck, A., and Stoler, M. H. A molecular portrait of human papillomavirus carcinogenesis. Cancer Cells, 7: 197-208, 1989.
8. Stoler, M. H., Rhodes, C. R., Whitbeck, A., Wolinsky, S. M., Chow, L. T., and Broker, T. R. Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Human Pathol., 23: 117-128, 1992.
9. Choo, K. B., Chong, K. Y., Liew, L. N., Hsu, H. C., and Cheng, W. T. Unregulated and basal transcriptional activities of the regulatory sequence of the type 18 human papillomavirus genome in transgenic mice. Virology, 188: 378-383, 1992.
10. Cid, A., Auewarakul, P., Garcia-Carranca, A., Ovseiovich, R., Gaissert, H., and Gissmann, L. Cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region in transgenic mice and its modulation by tetradecanoyl phorbol acetate and glucocorticoids. J. Virol., 67: 6742-6752, 1993.
11. Mack, D. H., and Laimins, L. A. A keratinocyte-specific transcription factor, KRF-1, interacts with AP-1 to activate expression of human papillomavirus type 18 in squamous epithelial cells. Proc. Natl. Acad. Sci. USA, 88: 9102-9106, 1991.
12. Hoppe-Seyler, F., and Butz, K. A novel cis-stimulatory element maps to the 5′ portion of the human papillomavirus type 18 upstream regulatory region and is functionally dependent on a sequence-aberrant Sp1 binding site. J. Gen. Virol., 74: 281-286, 1993.
13. Offord, E. A., and Beard, P. A member of the activator protein 1 family found in keratinocytes but not in fibroblasts required for transcription from a human papillomavirus type 18 promoter. J. Virol., 64: 4792-4798, 1990.
14. Thierry, F., Spyrou, G., Yaniv, M., and Howley, P. Two AP1 sites binding junB are essential for human papillomavirus type 18 transcription in keratinocytes. J. Virol., 66: 3740-3748, 1992.
15. Hoppe-Seyler, F., Butz, K., and zur Hausen, H. Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1. J. Virol., 65: 5613-5618, 1991.
16. O'Connor, M., and Bernard, H. U. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element. Virology, 207: 77-88, 1995.
17. Gloss, B., and Bernard, H. U. The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J. Virol., 64: 5577-5584, 1990.
18. Dong, G., Broker, T. R., and Chow, L. T. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J. Virol., 68: 1115-1127, 1994.
19. Tan, S. H., Leong, L. E., Walker, P. A., and Bernard, H. U. The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J. Virol., 68: 6411-6420, 1994.
20. Chong, T., Apt, D., Gloss, B., Isa, M., and Bernard, H. U. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription. J. Virol., 65: 5933-5943, 1991.
21. Apt, D., Chong, T., Liu, Y., and Bernard, H. U. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16. J. Virol., 67: 4455-4463, 1993.
22. Dollard, S. C., Broker, T. R., and Chow, L. T. Regulation of the human papillomavirus type 11 E6 promoter by viral and host transcription factors in primary human keratinocytes. J. Virol., 67: 1721-1726, 1993.
23. Bauknecht, T., Angel, P., Royer, H. D., and zur Hausen, H. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: interaction with the transcriptional repressor YY1. EMBO J., 11: 4607-4617, 1992.
24. Bauknecht, T., Jundt, F., Herr, I., Oehler, T., Delius, H., Shi, Y., Angel, P., and zur Hausen, H. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J. Virol., 69: 1-12, 1995.
25. O'Connor, M. J., Tan, S. H., Tan, C. H., and Bernard, H. U. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J. Virol., 70: 6529-6539, 1996.
26. Gloss, B., Bernard, H. U., Seedorf, K., and Klock, G. The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones. EMBO J., 6: 3735-3743, 1987.
27. Chan, W. K., Klock, G., and Bernard, H. U. Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J. Virol., 63: 3261-3269, 1989.
28. Mittal, R., Tsutsumi, K., Pater, A., and Pater, M. M. Human papillomavirus type 16 expression in cervical keratinocytes: role of progesterone and glucocorticoid hormones. Obstet. Gynecol., 81: 5-12, 1993.
29. Ishiji, T., Lace, M. J., Parkkinen, S., Anderson, R. D., Haugen, T. H., Cripe, T. P., Xiao, J. H., Davidson, I., Chambon, P., and Turek, L. P. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in keratinocytes and cervical carcinoma cells. EMBO J., 11: 2271-2281, 1992.
30. Chin, M. T., Broker, T. R., and Chow, L. T. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation. J. Virol., 63: 2967-2976, 1989.
31. Angel, P., and Karin, M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta, 1072: 129-157, 1991.
32. Welter, J. F., and Eckert, R. L. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene, 11: 2681-2687, 1995.
33. Yukawa, K., Yasui, T., Yamamoto, A., Shiku, H., Kishimoto, T., and Kikutani, H. Epoc-1: a POU-domain gene expressed in murine epidermal basal cells and thymic stromal cells. Gene (Amst.), 133: 163-169, 1993.
34. Anderson, B., Schonemann, M. D., Flynn, S. E., Pearse, R. V., Singh, H., and Rosenfeld, M. G. Skn-1a and Skn-1i: two functionally distinct oct-2-related factors expressed in epidermis. Science (Washington DC), 260: 78-82, 1993.
35. Faus, I., Hsu, H., and Fuchs, E. Oct-6: a regulator of keratinocyte gene expression in stratified squamous epithelia. Mol. Cell. Biol., 14: 3263-3275, 1994.
36. Wilson, J. L., Dollard, S. C., Chow, L. T., and Broker, T. R. Epithelial-specific gene expression during differentiation of stratified primary human keratinocyte cultures. Cell Growth & Differ., 3: 471-483, 1992.
37. Dollard, S. C., Wilson, J. L., Demeter, L. M., Bonnez, W., Reichman, R. C., Broker, T. R., and Chow, L. T. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev., 6: 1131-1142, 1992.
38. Meyers, C., Frattini, M. G., Hudson, J. B., and Laimins, L. A. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science (Washington DC), 257: 971-973, 1992.
39. Frattini, M. G., Lim, H. B., and Laimins, L. A. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl. Acad. Sci. USA, 93: 3062-3067, 1996.
40. Cheng, S., Schmidt-Grimminger, D-C., Murant, T., Broker, T. R., and Chow, L. T. Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev., 9: 2335-2349, 1995.
41. Staedel, C., Remy, J. S., Hua, Z., Broker, T. R., Chow, L. T., and Behr, J. P. High-efficiency transfection of primary human keratinocytes with positively charged lipopolyamine:DNA complexes. J. Invest. Dermatol., 102: 768-772, 1994.
42. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
43. Dubay, J. W., Roberts, S. J., Brody, B., and Hunter, E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol., 66: 4748-4756, 1992.
44. Butz, K., and Hoppe-Seyler, F. Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region. J. Virol., 67: 6476-6486, 1993.
45. Royer, H. D., Freyaldenhoven, M. P., Napierski, I., Spitkovsky, D. D., Bauknecht, T., and Dathan, N. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated. Nucleic Acids Res., 19: 2363-2371, 1991.
46. Chong, T., Chan, W. K., and Bernard, H. U. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res., 18: 465-470, 1990.
47. Kyo, S., Tam, A., and Laimins, L. A. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors. Virology, 211: 184-197, 1995.
48. Hoppe-Seyler, F., and Butz, K. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Nucleic Acids Res., 20: 6701-6706, 1992.
49. Luscher, B., Mitchell, P. J., Williams, T., and Tjian, R. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers. Genes Dev., 3: 1507-1517, 1989.
50. Mitchell, P. J., Timmons, P. M., Hebert, J. M., Rigby, P. W., and Tjian, R. Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev., 5: 105-119, 1991.
51. Snape, A. M., Winning, R. S., and Sargent, T. D. Transcription factor AP-2 is tissue-specific in Xenopus and is closely related or identical to keratin transcription factor 1 (KTF-1). Development (Camb.), 113: 283-293, 1991.
52. Leask, A., Byrne, C., and Fuchs, E. Transcription factor AP2 and its role in epidermal-specific gene expression. Proc. Natl. Acad. Sci. USA, 88: 7948-7952, 1991.
53. Medina-Martinez, O., Morales, P. N., Yaniv, M., Garcia, C. A., and Thierry, F. A single element mediates glucocorticoid hormone response of HPV18 with no functional interactions with AP1 or hbrm. Virology, 217: 392-396, 1996.
54. Wilkinson, D. G., Bhatt, S., Ryseck, R-P., and Bravo, R. Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development (Camb.), 106: 465-471, 1989.
55. Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A., and Crawford, L. Human papillomavirus type 16 DNA cooperates with activated Ras in transforming primary cells. EMBO J., 6: 1741-1746, 1987.
56. Pater, M. M., Hughes, G. A., Hyslop, D. E., Nakshatri, H., and Pater, A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature (Lond.), 335: 832-835, 1988.
57. Kopan, R., Traska, G., and Fuchs, E. Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J. Cell Biol., 105: 427-440, 1987.
58. Aneskievich, B. J., and Fuchs, E. Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements. Mol. Cell. Biol., 12: 4862-4871, 1992.
59. Sibbet, G. J., and Campo, M. S. Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J. Gen. Virol., 71: 2699-2707, 1990.
60. Kyo, S., Inoue, M., Nishio, Y., Nakanishi, K., Akira, S., Inoue, H., Yutsudo, M., Tanizawa, O., and Hakura, A. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the non-coding region. J. Virol., 67: 1058-1066, 1993.
61. Wang, H., Liu, K., Yuan, F., Berdichevsky, L., Taichman, L. B., and Auborn, K. C/EBPβ is a negative regulator of human papillomavirus type 11 in keratinocytes. J. Virol., 70: 4839-4844, 1996.
62. May, M., Dong, X. P., Beyer-Finkler, E., Stubenrauch, F., Fuchs, P. G., and Pfister, H. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. EMBO J., 13: 1460-1466, 1994.
63. Shrivastava, A., and Calame, K. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1. Nucleic Acids Res., 22: 5151-5155, 1994.
64. Danos, O., and Mulligan, R. C. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc. Natl. Acad. Sci. USA, 85: 6460-6464, 1988.
65. Markowitz, D., Goff, S., and Bank, A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology, 167: 400-406, 1988.
66. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2, vol. 2, pp. 10.59-10.63. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.